Happy Holidays and New year from the EMDB! Please be advised that the EMDB team will be operating at reduced capacity between December 15th - January 12th. With this in mind we would ask that you be prepared for longer reply times through both our helpdesk system and the OneDep deposition system. well done on a productive 2025, wishing you all the best and we will see you in 2026!

EMD-35036

Single-particle
3.9 Å
EMD-35036 Deposition: 23/12/2022
Map released: 27/12/2023
Last modified: 27/12/2023
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-35036

SARS-CoV2 spike protein with ACE2 decoy.no ACE2 decoy binding

EMD-35036

Single-particle
3.9 Å
EMD-35036 Deposition: 23/12/2022
Map released: 27/12/2023
Last modified: 27/12/2023
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Severe acute respiratory syndrome coronavirus 2
Sample: SARS-CoV2 spike protein with ACE2 decoy, no ACE2 decoy binding.

Deposition Authors: Kishikawa J, Hirose M , Kato T , Okamoto T
An inhaled ACE2 decoy confers protection against SARS-CoV-2 infection in preclinical models.
PUBMED: 37647387
DOI: doi:10.1126/scitranslmed.adi2623
ISSN: 1946-6242